NCT03005717 - Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

December 22, 2016

Primary Completion Date

June 2, 2017

Study Completion Date

June 2, 2017

Conditions

Submental Fat

Interventions

DRUG

LIPO-202

DRUG

Placebo for LIPO-202

Lyophile manufactured to mimic LIPO-202 lyophile.

Trial Locations (11)

Juva Skin & Laser Center, New York

Skin Research Institute, Coral Gables

Tennessee Clinical Research Center, Nashville

Grekin Skin Institute, Warren

Minnesota Clinical Study Center, Fridley

Mercy Research, Washington

Skin Specialists, PC, Omaha

Westlake Dermatology Clinical Research Center, Austin

AboutSkin Research, Greenwood Village

Clinical Testing of Beverly Hills, Beverly Hills

Ablon Skin Institute And Research Center, Manhattan Beach